Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary

Junnichi Ishii1, Kosuke Kashiwabara2, Yukio Ozaki3

  • 1Department of Clinical Laboratory, Bantane Hospital, Fujita Health University School of Medicine.

Insights

Small dense low-density cholesterol (sdLDL-C) is linked to cardiovascular risk in statin-treated patients. High-dose statin therapy effectively lowers this risk for individuals with the highest sdLDL-C levels.

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Pharmacotherapy

Background:

  • Small dense low-density cholesterol (sdLDL-C) is an independent risk factor for cardiovascular disease.
  • Statin therapy is a cornerstone in managing coronary artery disease (CAD), but its effectiveness may vary based on lipid profiles.

Purpose of the Study:

  • To investigate the association between sdLDL-C levels and the risk of major adverse cardiovascular events (MACE) in patients with stable CAD receiving high- or low-dose statin therapy.
  • To determine if high-dose statin therapy offers differential benefits in reducing MACE based on baseline sdLDL-C levels.

Main Methods:

  • A prospective case-cohort study was conducted within the REAL-CAD randomized trial.
  • Serum sdLDL-C was measured at baseline and 6 months in 497 MACE cases and 1543 randomly selected participants.
  • Patients received either high-dose (4 mg/d) or low-dose (1 mg/d) pitavastatin.

Main Results:

  • High-dose pitavastatin significantly reduced sdLDL-C compared to low-dose therapy.
  • In patients on low-dose statins, higher baseline sdLDL-C was associated with increased MACE risk, independent of LDL-C.
  • High-dose statins reduced MACE risk by 46% in the highest sdLDL-C quartile but increased risk in the lowest quartile, indicating a significant interaction.

Conclusions:

  • sdLDL-C is a significant predictor of cardiovascular risk in statin-treated CAD patients, independent of LDL-C.
  • High-dose statin therapy mitigates cardiovascular risk in patients with elevated baseline sdLDL-C.
  • The findings highlight the importance of assessing sdLDL-C for personalized statin therapy selection in CAD patients.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
943
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
388
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
62
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
333
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
151
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
732